Robert C. Getts
Director/Miembro de la Junta en Genisphere LLC .
Perfil
Robert C.
Getts is currently a Director at Genisphere LLC.
Previously, he worked as a Principal at Philadelphia College of Osteopathic Medicine.
He holds a doctorate degree from Lehigh University and undergraduate and graduate degrees from the University of Scranton.
Cargos activos de Robert C. Getts
| Empresas | Cargo | Inicio |
|---|---|---|
Genisphere LLC
 Genisphere LLC Electronic Equipment/InstrumentsElectronic Technology Genisphere LLC manufactures kits and reagents used for the ultra-sensitive detection of nucleic acids and proteins. Its solutions are primarily based on its proprietary whole transcriptome RNA Amplification processes, miRNA labeling methodologies, and 3DNA Dendrimer Nanotechnology. The firm's combined technologies permit the interrogation and ultra-sensitive detection of a wide range of biomolecules on a variety of detection platforms, including microarrays, flow and bead based assays, ELISAs, lateral flow assays and RNA sequencing. The company was founded in 1997 and is headquartered in Hatfield, PA. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Robert C. Getts.
| Empresas | Cargo | Fin |
|---|---|---|
| Philadelphia College of Osteopathic Medicine | Corporate Officer/Principal | - |
Formación de Robert C. Getts.
| University of Scranton | Graduate Degree |
| Lehigh University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Genisphere LLC
Genisphere LLC Electronic Equipment/InstrumentsElectronic Technology Genisphere LLC manufactures kits and reagents used for the ultra-sensitive detection of nucleic acids and proteins. Its solutions are primarily based on its proprietary whole transcriptome RNA Amplification processes, miRNA labeling methodologies, and 3DNA Dendrimer Nanotechnology. The firm's combined technologies permit the interrogation and ultra-sensitive detection of a wide range of biomolecules on a variety of detection platforms, including microarrays, flow and bead based assays, ELISAs, lateral flow assays and RNA sequencing. The company was founded in 1997 and is headquartered in Hatfield, PA. | Electronic Technology |
- Bolsa de valores
- Insiders
- Robert C. Getts
